ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ACOR Company Profile and Key Details

NASDAQ : ACOR

Acorda Therapeutics, Inc.

$0.66

-0.209-24.02%

At Close 4:00 PM

Not Actively Trading

66.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ACOR Stock Price Chart

Stock Price Today

Acorda Therapeutics, Inc. (ACOR) stock declined over -24.02%, trading at $0.66 on NASDAQ, down from the previous close of $0.87. The stock opened at $0.78, fluctuating between $0.61 and $0.85 in the recent session.

Stock Snapshot

0.87

Prev. Close

0.78

Open

821.03K

Market Cap

1.24M

Number of Shares

0.6116

Day Low

0.85

Day High

-0.00324704033010758

P/E Ratio

97.86%

Free Float in %

-203.57

EPS (TTM)

-163.79

Book Value

-14.77

Cash Flow per Share

321.67K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 07, 2024	0.80	0.88	0.75	0.88	5.34K
May 06, 2024	0.85	0.90	0.80	0.80	10.99K
May 03, 2024	0.85	0.92	0.83	0.85	10.22K
May 02, 2024	0.85	0.90	0.80	0.85	16.39K
May 01, 2024	0.68	0.89	0.68	0.85	19.02K
Apr 30, 2024	0.90	0.90	0.70	0.70	19.43K
Apr 29, 2024	0.78	0.90	0.75	0.90	39.38K
Apr 26, 2024	0.72	0.83	0.67	0.73	54.23K
Apr 25, 2024	0.55	0.84	0.55	0.75	37.62K
Apr 24, 2024	0.51	0.65	0.40	0.55	63.39K
Apr 23, 2024	0.46	0.64	0.46	0.52	70.03K
Apr 22, 2024	0.39	0.49	0.39	0.46	44.84K
Apr 19, 2024	0.35	0.47	0.35	0.44	40.19K
Apr 18, 2024	0.35	0.40	0.33	0.38	32.08K
Apr 17, 2024	0.40	0.40	0.32	0.34	45.54K
Apr 16, 2024	0.38	0.39	0.33	0.38	65.87K
Apr 15, 2024	0.40	0.43	0.27	0.40	209.57K
Apr 12, 2024	0.25	0.60	0.25	0.44	119.34K
Apr 11, 2024	0.78	0.85	0.61	0.66	416.93K
Apr 10, 2024	1.04	1.04	0.81	0.88	343.87K

Contact Details

Ardsley, NY 10502

United States

Website: https://www.acorda.comContact: 914 347 4300

About Company

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.

Frequently Asked Questions

What is the current Acorda Therapeutics, Inc. (ACOR) stock price?

Acorda Therapeutics, Inc. (NASDAQ: ACOR) stock price is $0.66 in the last trading session. During the trading session, ACOR stock reached the peak price of $0.85 while $0.61 was the lowest point it dropped to. The percentage change in ACOR stock occurred in the recent session was -24.02% while the dollar amount for the price change in ACOR stock was -$0.21.

ACOR's industry and sector of operation?

The NASDAQ listed ACOR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Acorda Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ACOR?

Mr. Kerry M. Clem
Chief Commercial Officer
Mr. Andrew Mayer J.D.
Senior Vice President
Ms. Tierney Saccavino
Executive Vice President of Corporation Communications
Dr. Burkhard Blank M.D.
Interim Head of Drug Safety
Sofia Ali
Senior Vice President of Operations & Strategic Planning
Ms. Felicia Vonella
Vice President of Investor Relations
Ms. Denise J. Duca
Executive Vice President of HR
Mr. Michael A. Gesser M.B.A.
Chief Financial Officer
Mr. Neil S. Belloff Esq.
Gen. Counsel & Corporation Sec.
Dr. Ron Cohen M.D.
Founder, Chief Executive Officer, Pres & Director
Mr. Robert Morales
Interim Principal Accounting Officer, Principal Financial Officer, Vice President of Fin. & Controller

How ACOR did perform over past 52-week?

ACOR's closing price is 8.08% higher than its 52-week low of $0.61 where as its distance from 52-week high of $24.20 is -97.27%.

How many employees does ACOR have?

Number of ACOR employees currently stands at 102.

Link for ACOR official website?

Official Website of ACOR is: https://www.acorda.com

How do I contact ACOR?

ACOR could be contacted at phone 914 347 4300 and can also be accessed through its website. ACOR operates from 420 Saw Mill River Road, Ardsley, NY 10502, United States.

How many shares of ACOR are traded daily?

ACOR stock volume for the day was 321.67K shares. The average number of ACOR shares traded daily for last 3 months was 125.68K.

What is the market cap of ACOR currently?

The market value of ACOR currently stands at $821.03K with its latest stock price at $0.66 and 1.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	102
Beta	1.46
Sales or Revenue	$117.63M
5Y Sales Change%	-0.921%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic